Dietary carbohydrate & glycemic index effects on oxidation & inflammation
膳食碳水化合物
基本信息
- 批准号:7800880
- 负责人:
- 金额:$ 15.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-10 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAntibodiesAntigen-Antibody ComplexAntioxidantsAtherosclerosisBiological MarkersBlood PressureC-reactive proteinCarbohydratesConsumptionCross-Over StudiesDietDiet ModificationDietary CarbohydratesDietary PracticesEnrollmentFatty acid glycerol estersGlycemic IndexHypertensionHypotensionInflammationInsulinIntakeInterleukin-1Interleukin-6IsoprostanesLipid PeroxidationLipidsLow Density Lipoprotein oxidationMacronutrients NutritionMeasurementMeasuresMonocyte Chemoattractant ProteinsOutcomeOxidative StressParentsParticipantPathogenesisPeptidesPrincipal InvestigatorProcessProteinsRandomizedReactive Oxygen SpeciesResearch PersonnelRiskRisk FactorsRisk ReductionSerumStagingUniversitiesUrineabstractingin vivoinflammatory markerinsightinsulin sensitivityoral glucose toleranceoxidationoxidized low density lipoproteinpost gamma-globulinspublic health relevance
项目摘要
DESCRIPTION (provided by applicant):
The direct relationship between traditional CVD risk factors and risk of atherosclerosis is well established. Dietary modifications which lower blood pressure and lipids provide a likely explanation for much of the risk reduction. However, oxidative stress, including oxidation of LDL-c (oxLDL) appears to be an important, if not obligatory step in the pathogenesis of atherosclerosis and may accelerate this process which is marked by inflamation (Steinberg, 1989). Measurement of inflammation and oxidative stress using serum and urine biomarkers may offer insight into mechanisms of CVD risk reduction beyond that which is predicted by lipids or other CVD risk factors alone. In this application we propose to measure the effects of dietary patterns that vary the type (high and low glycemic index) and the amount of carbohydrate in the diet (high carbohydrate and low carbohydrate) on markers of inflammation and oxidative stress. This study will be conducted within the setting of the OMNI-CARB trial (Optimal Macronutrient Intake and Carbohydrates)- a randomized cross over trial of 160 adults with prehypertension or stage 1 hypertension enrolling participants between 2008 and 2011 at Johns Hopkins and Harvard. The applicant is a co-investigator and this application has the full support and approval of the Principal Investigator (Frank Sacks, Harvard University). The primary aim of the OMNI-CARB study is to address the efficacy, separate and combined, of reducing carbohydrate from a high level (58% kcal) to a low level (43% kcal) and of lowering the glycemic index from a high level (glycemic index>85) to a low level (glycemic index<55) on the major established diet-related CVD risk factors, as well as insulin sensitivity. Measurement of biomarkers reflective of oxidative stress and inflammation are particularly relevant outcomes in this trial since modifying the glycemic index within a fixed macronutrients diet (carbohydrate, protein and fats held constant) is expected to results in only modest effects on serum lipids and other traditional CVD risk factors (blood pressure). We hypothesize that consumption of a fixed "low carbohydrate diet" and "low glycemic index" diet will decrease oxidative stress and inflammation compared with consumption an isocaloric "high carbohydrate" diet and "high glycemic index" diet. PUBLIC HEALTH RELEVANCE: In this application we propose to measure the effects of dietary patterns that vary the type (high and low glycemic index) and the amount of carbohydrate in the diet (high carbohydrate and low carbohydrate) on markers of inflammation and oxidative stress. This study will be conducted within the setting of the OMNI-CARB trial (Optimal Macronutrient Intake and Carbohydrates)- a randomized cross over trial of 160 adults with prehypertension or stage 1 hypertension enrolling participants between 2008 and 2011 at Johns Hopkins and Harvard. We hypothesize that consumption of a fixed "low carbohydrate diet" and "low glycemic index" diet will decrease oxidative stress and inflammation compared with consumption an isocaloric "high carbohydrate" diet and "high glycemic index" diet. (End of Abstract)
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edgar Raymond Miller其他文献
Edgar Raymond Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edgar Raymond Miller', 18)}}的其他基金
A RANDOMIZED TRIAL OF TAILORED DIETARY ADVICE OR MINERAL SUPPLEMENTS TO LOWER BLO
针对降低 BLO 的定制饮食建议或矿物质补充剂的随机试验
- 批准号:
8155034 - 财政年份:2010
- 资助金额:
$ 15.61万 - 项目类别:
Omega 3 Fatty Acid Supplementation in Diabetic Kidney Disease
补充 Omega 3 脂肪酸治疗糖尿病肾病
- 批准号:
7934695 - 财政年份:2009
- 资助金额:
$ 15.61万 - 项目类别:
Dietary carbohydrate & glycemic index effects on oxidation & inflammation
膳食碳水化合物
- 批准号:
8034234 - 财政年份:2009
- 资助金额:
$ 15.61万 - 项目类别:
Omega 3 Fatty Acid Supplementation in Diabetic Kidney Disease
补充 Omega 3 脂肪酸治疗糖尿病肾病
- 批准号:
7660203 - 财政年份:2009
- 资助金额:
$ 15.61万 - 项目类别:
Dietary carbohydrate & glycemic index effects on oxidation & inflammation
膳食碳水化合物
- 批准号:
7687879 - 财政年份:2009
- 资助金额:
$ 15.61万 - 项目类别:
Dietary carbohydrate & glycemic index effects on oxidation & inflammation
膳食碳水化合物
- 批准号:
8242082 - 财政年份:2009
- 资助金额:
$ 15.61万 - 项目类别:
AFRICAN-AMERICAN STUDY OF KIDNEY DISEASE AND HYPERTENSION (AASK)
非裔美国人肾脏疾病和高血压研究 (AASK)
- 批准号:
7200661 - 财政年份:2005
- 资助金额:
$ 15.61万 - 项目类别:
African-American Study of Kidney Disease and Hypertension (AASK)
非裔美国人肾脏疾病和高血压研究 (AASK)
- 批准号:
7044580 - 财政年份:2003
- 资助金额:
$ 15.61万 - 项目类别:
DIETARY PATTERNS, ANTIOXIDANTS AND LIPID PEROXIDATION
饮食模式、抗氧化剂和脂质过氧化
- 批准号:
6030426 - 财政年份:1998
- 资助金额:
$ 15.61万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 15.61万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 15.61万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 15.61万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 15.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 15.61万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 15.61万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 15.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)